STAT June 13, 2024
Elizabeth Schmidt

The Supreme Court unanimously shut down one of many troubling tugs of war over access to abortion. By tossing out FDA v. Alliance for Hippocratic Medicine, it quashed the utterly mistaken notion that the Food and Drug Administration improperly approved mifepristone, a drug used for medical abortion, nearly a quarter century ago.

This Texas-based case, which sought to roll back access to one of two abortion medications, was not really about anti-abortion doctors supposedly being harmed by the government’s actions. It was about a political drive to unfairly question and restrict a longstanding, safe, and sometimes necessary medical treatment to end pregnancies.

Mifepristone’s safety record is firm: it has been used in more than 630 clinical trials, 420 of which...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Patient / Consumer, Provider, States
America’s frustration with the health care industry
Five more Health and Aging Tech offerings from CES 2025
New Federal Guidance Puts Medical Debt Collectors On Notice
Digital Retail Platforms: The new concept of Pharma to sell directly to patients
Will Consumers Force Healthcare Leaders to Embrace Innovation?

Share This Article